SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-23-007648
Filing Date
2023-03-13
Accepted
2023-03-13 09:31:11
Documents
74
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ovid-20221231.htm   iXBRL 10-K 1662066
2 EX-23.1 ovid2022exhibit231.htm EX-23.1 2047
3 EX-31.1 ovid2022exhibit311.htm EX-31.1 8182
4 EX-31.2 ovid2022exhibit312.htm EX-31.2 8207
5 EX-32.1 ovid2022exhibit321.htm EX-32.1 6621
11 ovid-20221231_g1.gif GRAPHIC 158108
12 ovid-20221231_g2.jpg GRAPHIC 99994
13 ovid-20221231_g3.jpg GRAPHIC 98022
14 ovid-20221231_g4.jpg GRAPHIC 96597
  Complete submission text file 0001628280-23-007648.txt   8002231

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ovid-20221231.xsd EX-101.SCH 48959
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ovid-20221231_cal.xml EX-101.CAL 68791
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ovid-20221231_def.xml EX-101.DEF 201720
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ovid-20221231_lab.xml EX-101.LAB 622071
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ovid-20221231_pre.xml EX-101.PRE 382424
68 EXTRACTED XBRL INSTANCE DOCUMENT ovid-20221231_htm.xml XML 913270
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38085 | Film No.: 23725993
SIC: 2834 Pharmaceutical Preparations